Skip to main content

PharmacoEconomics

Ausgabe 5/1998

Inhalt (15 Artikel)

Current Opinion

Reassessing the Relevance of Pharmacoeconomic Analyses in Formulary Decisions

Jeffrey A. Johnson, Erwin Friesen

Leading Article

The Use of the Bootstrap Statistical Method for the Pharmacoeconomic Cost Analysis of Skewed Data

Alain Desgagné, Anne-Marie Castilloux, Jean-François Angers, Jacques Le Lorier

Leading Article

Should Antibacterials Be Deregulated?

Joan Rovira, Montserrat Figueras, Josep L. Segú

Original Research Article

Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic Patients

George Dranitsaris, Peter Phillips, Coleman Rotstein, Anitasha Puodziunas, Steve Shafran, Gary Garber, Fiona Smaill, Irving Salit, Mark Miller, Kurt Williams, John Conly, Joel Singer, Steve Ioannou

Original Research Article

Predicting Hospitalisation of Patients with Diabetes Mellitus

Samir K. Bhattacharyya

Original Research Article

Linking the Health Utilities Index to National Medical Expenditure Survey Data

John A. Rizzo, Steven Pashko, Rebecca Friedkin, John Mullahy, Jody L. Sindelar

Adis Pharmacoeconomic Drug Evaluation

Fluoxetine

Michelle I. Wilde, Paul Benfield

Correspondence

How to Calculate Indirect Costs in Economic Evaluations

Werner B. F. Brouwer, Marc A. Koopmanschap

Correspondence

Correspondence

Bengt Liljas

Original Research Article

Cost Analysis of the Treatment of Schizophrenia in the UK

Stephen Almond, Owen O’ Donnell

Original Research Article

The Economic Cost of Multiple Sclerosis in Sweden in 1994

Freddie Henriksson, Bengt Jönsson

Original Research Article

Economic Evaluation of Multiple Sclerosis in the UK, Germany and France

Nuala Murphy, C. Confavreux, J. Haas, N. König, E. Roullet, M. Sailer, M. Swash, C. Young, J. -L. Mérot

Original Research Article

Cost Effectiveness of Early Treatment with Oral Aciclovir in Adult Chickenpox

Kenneth J. Smith, Mark S. Roberts